ArticleCancer biology & therapy2010

Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.

Colin Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.